On Tuesday, Cassava Sciences Inc (NASDAQ: SAVA) opened higher 1.27% from the last session, before settling in for the closing price of $2.36. Price fluctuations for SAVA have ranged from $2.23 to $42.20 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 62.79% at the time writing. With a float of $41.80 million, this company’s outstanding shares have now reached $47.98 million.
Considering the fact that the conglomerate employs 29 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 58.82%, operating margin of -5985.86%, and the pretax margin is -752.3%.
Cassava Sciences Inc (SAVA) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Cassava Sciences Inc is 13.11%, while institutional ownership is 29.19%. The most recent insider transaction that took place on Nov 29 ’24, was worth 15,480. In this transaction Chief Medical Officer of this company sold 4,000 shares at a rate of $3.87, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 29 ’24, when Company’s Chief Financial Officer sold 59,800 for $3.86, making the entire transaction worth $230,828. This insider now owns 11,500 shares in total.
Cassava Sciences Inc (SAVA) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 62.79% per share during the next fiscal year.
Cassava Sciences Inc (NASDAQ: SAVA) Trading Performance Indicators
Check out the current performance indicators for Cassava Sciences Inc (SAVA). In the past quarter, the stock posted a quick ratio of 3.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.37, a number that is poised to hit -0.58 in the next quarter and is forecasted to reach -0.43 in one year’s time.
Technical Analysis of Cassava Sciences Inc (SAVA)
Compared to the last year’s volume of 2.3 million, its volume of 1.05 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 22.02%. Additionally, its Average True Range was 0.30.
During the past 100 days, Cassava Sciences Inc’s (SAVA) raw stochastic average was set at 0.50%, which indicates a significant decrease from 19.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.86% in the past 14 days, which was lower than the 299.65% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.31, while its 200-day Moving Average is $18.48. Nevertheless, the first resistance level for the watch stands at $2.45 in the near term. At $2.50, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.56. If the price goes on to break the first support level at $2.34, it is likely to go to the next support level at $2.28. Now, if the price goes above the second support level, the third support stands at $2.23.
Cassava Sciences Inc (NASDAQ: SAVA) Key Stats
There are currently 48,110K shares outstanding in the company with a market cap of 114.98 million. Presently, the company’s annual sales total 0 K according to its annual income of -97,220 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -27,940 K.
